Fundz

Dewpoint Therapeutics Announces Completion Of $150 Million Series C Financing

PRIVATEFeb 03, 2022

Amount Raised

$150 Million

Round Type

Series C

BostonBiotechnologyHealth CareScience And Engineeringresearch

Description

Dewpoint Therapeutics, Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing.

Quick answer

Dewpoint Therapeutics raised $150 Million in a Series C round, dated February 3, 2022. Dewpoint Therapeutics is based in Boston, Massachusetts, United States.

How much did Dewpoint Therapeutics raise?
Dewpoint Therapeutics raised $150 Million in a Series C round on February 3, 2022.
What does Dewpoint Therapeutics do?
Dewpoint Therapeutics is the first company to apply an emerging understanding of biomolecular condensates to drug discovery.
Where is Dewpoint Therapeutics based and how big is it?
Dewpoint Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 69 employees.
Who are the decision-makers at Dewpoint Therapeutics?
Fundz holds 1 contact at Dewpoint Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and research around the same time

Companies in the same sectors as Dewpoint Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Triumvira Immunologics Inc. raised an undisclosed amount (Series A) on March 17, 2022.
  • MAIA Biotechnology raised $2.4M (Seed) on March 16, 2022.
  • 2seventy bio raised $170M (Post-IPO Equity) on March 16, 2022.
  • Sherlock Biosciences raised $80M on March 15, 2022.
  • PrognomiQ raised $46M (Funding Round) on March 15, 2022.
  • IMPACT Therapeutics raised an undisclosed amount (Series D) on March 14, 2022.

Who to call at Dewpoint Therapeutics, and when

A new round usually means Dewpoint Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dewpoint Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dewpoint Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dewpoint Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dewpoint Therapeutics

Location

451 D Street, Suite 104

Boston, Massachusetts, United States

About

Dewpoint Therapeutics is the first company to apply an emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Novo Nordisk, Evotec and Chemify. Dewpoint scientists work to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dewpoint Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Dewpoint Therapeutics's next move

See what Strategic adds

Dewpoint Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.